4//SEC Filing
Clayman Michael D. 4
Accession 0001209191-21-043522
CIK 0001419600other
Filed
Jun 27, 8:00 PM ET
Accepted
Jun 28, 6:04 PM ET
Size
7.4 KB
Accession
0001209191-21-043522
Insider Transaction Report
Form 4
Clayman Michael D.
DirectorPresident and CEO
Transactions
- Award
Common Stock
2021-06-21$7.78/sh+1,700$13,226→ 348,840 total
Holdings
- 24,600(indirect: By Trust)
Common Stock
- 388,683(indirect: By LLC)
Common Stock
- 373,769(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]This Form 4 is being filed voluntarily to report the acquisition of 1,700 shares by the Reporting Person on June 21, 2021, pursuant to the Issuer's Employee Stock Purchase Plan.
- [F2]Shares held by Versant Development Fund III, LLC. The Reporting Person is a manager and minority member of Versant Development Fund III, LLC. The Reporting Person disclaims any beneficial ownership of the shares held by Versant Development Fund III, LLC except to the extent of his pecuniary interest in these shares.
Documents
Issuer
Flexion Therapeutics Inc
CIK 0001419600
Entity typeother
Related Parties
1- filerCIK 0001597407
Filing Metadata
- Form type
- 4
- Filed
- Jun 27, 8:00 PM ET
- Accepted
- Jun 28, 6:04 PM ET
- Size
- 7.4 KB